Prediction of Outcomes of Brain Irradiation in Correlation with Molecular Subtypes in Patients with Metastatic Breast Cancer

Volume 27, Issue 4, April 2026, Pages 1303-1311

Ahmed Sohaib; Mohamed Alhefny; Mohamed Taher Amin; Yostena Mekhail

• View Article
• PDF 524.63 K

Differential Clinical Outcomes of Palliative Radiotherapy among Different Molecular Subtypes of Metastatic Breast Cancer: A Prospective Study

Volume 27, Issue 3, March 2026, Pages 1029-1035

Naveen Thimmaiah; Nirupama Naveen; Ayushee Saini; Uday Krishna; Mageshraja Kannan; Tanvir Pasha; Sridhar Poojar

• View Article
• PDF 451.23 K

Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation

Volume 24, Issue 6, June 2023, Pages 1955-1962

Shinya Takada; Hideki Maeda; Kengo Umehara; Sayuri Kuwahara; Mitsugu Yamamoto; Nobumoto Tomioka; Masato Takahashi; Kenichi Watanabe; Hirokazu Hashishita

• View Article
• PDF 515.88 K

Impact of Her-2 Overexpression on Survival of Patients with Metastatic Breast Cancer

Volume 18, Issue 10, October 2017, Pages 2673-2678

Giovana Tavares dos Santos; Natália Dressler Camillo; Maiquidieli Dal Berto; João Carlos Prolla; Ivana Beatrice Mânica da Cruz; Adriana Vial Roehe; Rosicler Luzia Brackmann; Keli Critine Reiter; Claudia Giuliano Bica

• View Article
• PDF 349.51 K

Aromatase Inhibition and Capecitabine Combination as 1st or 2nd Line Treatment for Metastatic Breast Cancer - a Retrospective Analysis

Volume 16, Issue 15, December 2015, Pages 6359-6364

• View Article
• PDF 459.1 K

Irinotecan as a Palliative Therapy for Metastatic Breast Cancer Patients after Previous Chemotherapy

Volume 15, Issue 24, December 2014, Pages 10745-10748

• View Article
• PDF 376.78 K

Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

Volume 15, Issue 1, January 2014, Pages 117-122

• View Article
• PDF 492.48 K

Efficacy and Safety of Trastuzumab Added to Standard Treatments for HER2-positive Metastatic Breast Cancer Patients

Volume 14, Issue 12, December 2013, Pages 7111-7116

• View Article
• PDF 855.05 K

Prognostic Significance of Human Epidermal Receptor (HER)-3 Immunohistochemical Expression in Patients with Metastatic Breast Cancer

Volume 14, Issue 7, July 2013, Pages 4115-4119

• View Article
• PDF 811.43 K

Prognostic Significance of Circulating Tumor Cells and SerumCA15-3 Levels in Metastatic Breast Cancer, Single CenterExperience, Preliminary Results

Volume 14, Issue 3, March 2013, Pages 1725-1729

• View Article
• PDF 470.73 K

Phase II Trial of Loubo® (Lobaplatin) and Pemetrexed for Patients with Metastatic Breast Cancer not Responding to Anthracycline or Taxanes

Volume 14, Issue 1, January 2013, Pages 413-417

• View Article
• PDF 422.62 K

Efficacy of Exemestane after Nonsteroidal Aromatase Inhibitor Use in Metastatic Breast Cancer Patients

Volume 13, Issue 3, March 2012, Pages 979-983

• View Article
• PDF 272.58 K